Flutiform FDA Approval Status
FDA Approved: No
Brand name: Flutiform
Generic name: fluticasone and formoterol
Dosage form: Inhalation Aerosol
Company: Vectura Group plc
Treatment for: Asthma
Flutiform (fluticasone and formoterol) metered dose inhaler is a corticosteroid and long-acting beta-agonist fixed-dose combination in development for the treatment of asthma.
Development Timeline for Flutiform
|Jun 10, 2009||SkyePharma Inc. Says FDA May Need More Flutiform Data|
|May 22, 2009||Skyepharma plc: Flutiform NDA Accepted for Review|
|Aug 6, 2007||SkyePharma PLC - Flutiform Progress Update|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.